BioMarin Pharmaceutical’s $200 Million Amended Credit Facility

Cahill represented the lead arrangers in the transaction.BioMarin Pharmaceutical Inc. completed an amendment to the $200,000,000 revolving credit facility. Proceeds from the credit facility will be used…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now